Product Browser

Advanced Search

User Log-In / Register

Site Map

Search & Browse Tips

How to use Your Briefcase

How to use Your Basket

Accommodation

Venue Information

Speaker Opportunities

Marketing Opportunities

Advertising Opportunities

Sponsors & Exhibitions

The SMi Pharmaceutical Sector produces conferences and publications covering areas as diverse as: Strategy and management of new developments in therapeutic drugs, Impact of biotechnological advances, Clinical development of new therapeutics, Commercialisation and marketing of new drugs, Global regulatory affairs, New regulations in the healthcare industry.

Special Partners - In partnership with SMi Group's complete Pharmaceutical portfolio

SMi Pharmaceutical conferences are attended by high level executives, on average two thirds of delegates are of Director level or higher from within the pharmaceutical, biotechnology and associated industries.

Forthcoming SMi events include the following:

Masterclass: Data Management in Medical Imaging
16th July 2009, London

Conference: Biological Production 2009
21st to 22nd September 2009, London

Executive Briefing: A Quality by Design (QbD) Framework for Biopharmaceutical Glycosylation During Production
23rd September 2009, London

Conference: Biomarkers in Clinical Trials
23rd to 24th September 2009, London

Executive Briefing: Protein Biomarkers in Clinical Development
22nd September 2009, London

Conference: KOL Knowledge Leaders
30th September to 1st October 2009, London

Executive Briefing: KOL Relationship Management & Segmentation
29th September 2009, London

Conference: Managing Partnerships with CROs
5th to 6th October 2009, London

Executive Briefing: Improving Project Management in a CRO Partnership
7th October 2009, London

Conference: Conducting Clinical Trials in Europe
12th to 13th October 2009, London

Executive Briefing: The Safety Aspects of Clinical Trial Reporting in the EU
14th October 2009, London

Conference: Nutraceuticals and Functional Foods
21st to 22nd October 2009, London

Executive Briefing: Health Claims Legislation: The Bumpy Road Towards an Approved Health Claim
20th October 2009, London

Conference: Point of Care Diagnostics - Market Adoption and Technology Trends
26th to 27th October 2009, London

Executive Briefing: How Do We Achieve Concordance Between POCT and Central Lab Tests?
28th October 2009, London

Conference: European Pharmaceutical Pricing & Reimbursement
28th to 29th October 2009,

Executive Briefing: Cooperation with Payors as a Means for Attaining Reimbursement
27th October 2009,

Conference: COPD: Novel Therapeutics and Management Strategies
16th to 17th November 2009, Munich

Executive Briefing: Inhalation - Technology and Formulation Challenges Into the Future
18th November 2009, Munich

Conference: Cell Based Assays
18th to 19th November 2009, London

Executive Briefing: Cell Based Assays and High Content Analysis
17th November 2009, London

Conference: Clinical Trials in CNS
25th to 26th November 2009, London

Executive Briefing: Effective Project Management in Clinical Trials
24th November 2009, London

Conference: Cold Chain Distribution
2nd to 3rd December 2009, London

Executive Briefing: Hidden Breaks � A reality check session exploring the real life threats to cold chain integrity
1st December 2009, London

Masterclass: Intellectual Property and Generics
8th December 2009, London

Masterclass: Accelerating Preclinical CMC Activities
8th December 2009, London

Masterclass: Supersaturation and Solubility in Formulation Excipients: Promoting a Compound�s BCS Class
9th December 2009, London

Masterclass: Writing Successful Pharmacovigilance Risk Management Plans
10th December 2009, London

Masterclass: Developing Personalized Cancer Therapies
11th December 2009, London


SMi Pharmaceutical conferences are attended by high level executives, on average two thirds of delegates are of Director level or higher from within the pharmaceutical, biotechnology and associated industries. Documentation and audio/video recordings are available for the following events:

	ADMET (2009)

	Clinical Trials in Cancer (2009)

	Pharmaceutical Portfolio & Product Life Cycle Management (2009)

	Key Opinion Leaders Europe (2009)

	Quantitative Polymerase Chain Reaction and Transcriptional Profiling (2009)

	RNAi, siRNA & miRNA (2009)

	Pain Therapeutics (2009)

	In Vitro Diagnostics (2009)

	Global Proteins Summit (2009)

	Clinical Trials Logistics (2009)

	Generics & Supergenerics (2009)

	Imaging in Oncology (2009)

	Pharmaceutical Packaging & Labelling Innovations (2009)

	Asthma & COPD (2009)

	Accelerating Patient Recruitment & Retention in Clinical Trials (2009)

	Superbugs & Superdrugs - A Focus on Antibacterials (2009)

	High Throughput Screening for Biological Systems (2009)

	Controlled Release (2009)

	Advances and Progress in Drug Design VIII (2009)

	Stem Cells: Drug Discovery and Therapeutics (2009)

	Pharmaceutical Parallel Trade (2009)

	Adaptive Designs in Clinical Drug Development (2009)

	Biomarkers Summit (2009)

	Electronic Laboratory Notebooks (2009)

	Pre-Filled Syringes (2009)

	Paediatric Clinical Trials (2009)

	Cold Chain Distribution (2008)

	Clinical Trials in CNS (2008)

	Cell-Based Assays (2008)

	European Pharmaceutical Pricing & Reimbursement (2008)

	Point of Care Diagnostics (2008)

	Nutraceuticals and Functional Foods (2008)

	Conducting Clinical Trials in Europe (2008)

	Key Opinion Leaders (2008)

	Metabolic Diseases (2008)

	Drug Delivery Global Summit (2008)

	ADMET (2008)

	Pharmaceutical Portfolio & Product Life Cycle Management (2008)

	Clinical Trials in Cancer (2008)

	Vaccines Summit (2008)

	RNAi, siRNA and miRNA 2008 (2008)

	Pain Therapeutics (2008)

	Molecular Diagnostics (2008)

	Global Protein Summit (2008)

	Clinical Trials Logistics (2008)

	Generics, Supergenerics and Patent Strategies (2008)

	Asthma & COPD (2008)

	Imaging in Oncology (2008)

	10th Annual Superbugs & Superdrugs Conference (2008)

	Pharmaceutical Pricing & Reimbursement in North America (2008)

	Accelerating Patient Recruitment and Retention in Clinical Trials (2008)

	Advances and Progress in Drug Design (2008)

	Pharmaceutical Packaging and Labelling Innovations (2008)

	Pharmaceutical Collaborations 2008 (2008)

	Parallel Trade (2008)

	Optimising Drug Formulation (2008)

	Adaptive Designs in Clinical Drug Development (2008)

	Biomarkers Summit (2008)

	Electronic Laboratory Notebooks (2008)

	Paediatric Clinical Trials (2008)

	Cold Chain Distribution (2007)

	Clinical Trials in CNS (2007)

	Anti-Arthritic Agents Conference (2007)

	European Pharmaceutical Pricing & Reimbursement (2007)

	Diabetes (2007)

	Nutraceuticals and Functional Foods (2007)

	Clinical Informatics: Data management, EDC and standards (2007)

	Conducting Clinical Trials in Europe (2007)

	Targeting Obesity Conference: Solutions and Therapeutics (2007)

	Drug Delivery Global Summit (2007)

	Pharmaceutical Intellectual Property (2007)

	Pharmaceutical Portfolio & Lifecycle Management Conference (2007)

	Pharmaceutical Pricing and Reimbursement in the UK (2007)

	Clinical Trials in Cancer (2007)

	Depression & Anxiety (2007)

	Point of Care Diagnostics - Market Opportunities & Technology Trends (2007)

	Pain Therapeutics (2007)

	Global Proteins Summit (2007)

	Pricing & Reimbursement in North America (2007)

	Phase IV Conference (2007)

	In-Silico ADMET (2007)

	Generics, Supergenerics & Patent Strategies (2007)

	Asthma & COPD (2007)

	Reporting Adverse Events (2007)

	Superbugs & Superdrugs (2007)

	Accelerating Patient Recruitment and Retention in Clinical Trials (2007)

	Clinical Trials Logistics (2007)

	Cancer Biomarkers 2007 (2007)

	Imaging in Oncology (2007)

	Drug Design VI (2007)

	Pharma Packaging & Labelling Conference (2007)

	Parallel Trade (2007)

	Optimising Drug Formulation (2007)

	Imaging In Neurology (2007)

	Adaptive Designs in Clinical Drug Development (2007)

	Therapeutic Antibodies (2007)

	Paediatric Clinical Trials (2007)

	Practical Approaches to Cardiac Safety (2007)

	Outsourcing Clinical Trials (2006)

	Advances in Anti-Inflammatory Therapeutics (2006)

	Clinical Trials in CNS (2006)

	European Pharmaceutical Pricing and Reimbursement 2006 (2006)

	Nutraceuticals & Functional Foods (2006)

	Conducting Clinical Trials in Europe (2006)

	Medical Devices (2006)

	European Wholesale and Distribution in the Pharmaceutical Industry 2006 (2006)

	Metabolic Diseases Forum: A Focus on Diabetes, Obesity & Related Disorders (2006)

	Pharmaceutical Stability Testing (2006)

	Drug Delivery Global Summit (2006)

	Depression & Anxiety (2006)

	Clinical Trials in Cancer (2006)

	Pharmaceutical Portfolio & Product Life Cycle Management (2006)

	Opportunities & Technology Trends in Global Diagnostic Testing Markets (2006)

	Pain Therapeutics (2006)

	Global Protein Summit (2006)

	Phase IV to Market Conference (2006)

	Vaccines (2006)

	Generics, Supergenerics & Patent Strategies (2006)

	Asthma & COPD II (2006)

	Reporting Adverse Events (2006)

	Superbugs & Superdrugs (2006)

	Accelerating Patient Recruitment in Clinical Trials (2006)

	Pharmaceutical Pricing & Reimbursement in North America (2006)

	Preclinical Models & Biomarkers (2006)

	Imaging in Oncology (2006)

	Drug Design V (2006)

	Pharmaceutical Packaging & Labelling (2006)

	A Risk-Based Approach To Computer Systems Validation (2006)

	Controlled Release (2006)

	Market Opportunities and Technology Trends in Point of Care Diagnostics (2006)

	Therapeutic Antibodies (2006)

	Innovating Clinical Drug Development (2006)

	High Throughput Screening (2006)

	Technology Transfer within the Pharmaceutical & Biotech Industries (2005)

	Clinical Trials in CNS (2005)

	Optimising Drug Formulation (2005)

	European Pharmaceutical Pricing & Reimbursement (2005)

	Market Opportunities & Technology Trends in Molecular Diagnostics (2005)

	Pharmaceutical Law - A Global Perspective (2005)

	Conducting Clinical Trials in Europe (2005)

	Outsourcing in the Pharmaceutical Industry (2005)

	European Wholesale & Distribution in the Pharmaceutical Industry 2005 (2005)

	Diabetes (2005)

	Pharmaceutical Stability Testing (2005)

	Drug Delivery Global Summit (2005)

	Opportunities & Technology Trends in Global Diagnostic Testing Markets (2005)

	Collaborations & Licensing in the Pharma & Biotech Industries (2005)

	Clinical Trials in Cancer (2005)

	Pain Therapeutics (2005)

	Global Protein Summit (2005)

	Anti-Arthritic Agents (2005)

	Asthma and COPD (2005)

	Accelerating Patient Recruitment in Clinical Trials (2005)

	Reporting Adverse Events (2005)

	Generics, Supergenerics & Patent Strategies (2005)

	Preclinical Models & Biomarkers (2005)

	Pharmaceutical Pricing & Reimbursement in North America (2005)

	Superbugs & Superdrugs (2005)

	Drug Design (2005)

	Market Opportunities & Technology Trends in Point of Care Diagnostics (2005)

	Obesity & Related Disorders (2005)

	Controlled Release (2005)

	Computer Systems Validation (2005)

	Nutraceuticals & Functional Foods 2005 (2005)

	High Throughput Screening (2005)

	Advances in Anti-Viral Therapeutics (2004)

	Securing the Pharmaceutical Supply Chain (2004)

	Clinical Trials in CNS (2004)

	European Wholesale & Distribution in the Pharmaceutical Industry (2004)

	Cosmeceuticals: Market Opportunities & Technology Trends (2004)

	Opportunities & Technology Trends in Molecular Diagnostics (2004)

	Conducting Clinical Trials in Europe II (2004)

	European Pharmaceutical Pricing & Reimbursement (2004)

	Diabetes (2004)

	Managing Clinical Trial Results (2004)

	Drug Delivery Global Summit (2004)

	From Hit to Lead to Candidate (2004)

	Neuroprotection and Neurorepair (2004)

	Pharmaceutical Stability Testing (2004)

	Neurodegenerative Disorders (2004)

	Opportunities & Technology Trends in Global Diagnostic Testing Markets (2004)

	Therapeutic Antibodies (2004)

	SMi's Global Cancer Event (2004)

	Pain Therapeutics (2004)

	Psychiatric Disorders (2004)

	Cold Chain Distribution (2004)

	Angiogenesis (2004)

	Protein Expression (2004)

	Asthma Therapeutics (2004)

	Collaborations & Licensing in the Pharma & Biotech Industries (2004)

	Advances in Anti-Arthritic Agents (2004)

	Market Opportunities & Technology Trends in Implantable Medical Devices (2004)

	Integrative Strategies to Improve the Efficiency of Drug Discovery (2004)

	Generics, Super Generics & Patent Strategies (2004)

	Vaccines (2004)

	Imaging in Oncology (2004)

	Chronic Obstructive Pulmonary Disease (2004)

	Biologics: Overcoming the Challenges of Development and Manufacture (2004)

	Superbugs & Superdrugs: A Focus on Antibacterials (2004)

	TBA (pharma) (2004)

	Pharmaceutical Packaging and Labelling (2004)

	Drug Design (2004)

	Pharmacoeconomics & Outcomes Research (2004)

	Antisense & siRNA Technologies (2004)

	Market Opportunities & Technology Trends in Point of Care Diagnostics (2004)

	Pharmaceutical Manufacturing Efficiency & Compliance (2004)

	Conducting Clinical Trials in Europe (2004)

	Controlled Release (2004)

	Prevention and Treatment of Allergy (2004)

	Nutraceuticals & Functional Foods (2004)

	Advances in High-Throughput Screening (2004)

	Preclinical Models & Biomarkers (2004)

	Pharmacogenomics (2003)

	Future Opportunities & Innovative Therapies for Cardiovascular Diseases (2003)

	Clinical Trials in CNS (2003)

	Advanced Computer Systems Validation (2003)

	Future Antivirals: Latest Developments in HIV, Hepatitis, Herpes, Influenza, RSV & SARS (2003)

	European Wholesale & Distribution in the Pharmaceutical Industry (2003)

	Market Opportunities & Technology Trends in Molecular Diagnostics (2003)

	Diabetes (2003)

	European Pharmaceutical Pricing and Reimbursement (2003)

	Anti-Inflammatory Therapeutics (2003)

	ADME/Tox Prediction (2003)

	Combating Pharmaceutical Fraud & Counterfeiting (2003)

	Clinical Trials and Data Management (2003)

	Test Event (2003)

	Cell & Gene Therapies (2003)

	Computer Systems Validation (2003)

	Treatment of Stroke & Neuroprotection (2003)

	Outsourcing of Drug Development (2003)

	Commercial Issues in Drug Delivery (2003)

	Pharmaceutical Stability Testing (2003)

	G-Protein Coupled Receptors (2003)

	Collaborations & Partnerships in the Pharmaceutical & Biotech Industries (2003)

	Opportunities and Technology Trends in Global Diagnostic Testing Markets (2003)

	Therapeutic Antibodies 2003 (2003)

	Pain Therapeutics (2003)

	Clinical Trials in Cancer (2003)

	Neurodegenerative Disorders (2003)

	Osteoporosis and Menopausal Disorders (2003)

	Depression and Anxiety (2003)

	Asthma Therapeutics (2003)

	Anti Arthritic Agents (2003)

	Kinases (2003)

	Target Validation (2003)

	Generics, Supergenerics and Patent Busting (2003)

	*Predictive In Silico Models* in Drug Discovery and Development (2003)**

	Biologics: Overcoming the Challenges of Development and Manufacture (2003)

	Key Trends and Issues in Cosmetics & Healthcare (2003)

	Cancer Drug Development: New Directions and Challenges (2003)

	Superbugs and Superdrugs : A Focus on Anti-Infectives (2003)

	Drug Design (2003)

	Obesity and Related Disorders (2003)

	Angiogenesis (2003)

	Antisense and SiRNA Technologies (2003)

	Controlled Release (2003)

	Microarray Technology : Commercial and Technical Issues (2003)

	Beyond the Genome (2003)

	Computer Systems Validation in the Pharmaceutical Industry (2003)

	Reducing the Attrition Rate in Drug Discovery (2003)

	Nutraceuticals, Functional Foods and Probiotics 2003 (2003)

	Portfolio Management in Pharmaceutical R & D (2003)

	Dermatological Disorders (2002)

	Clinical Trials in CNS (2002)

	European Wholesale and Distribution in the Pharmaceutical Industry (2002)

	Tissue Engineering (2002)

	Vaccines (2002)

	Diabetes 2002 (2002)

	Anti Ageing Therapies (2002)

	Pricing and Reimbursement in the Pharmaceutical Industry (2002)

	Prevention and Treatment of Allergy (2002)

	From Hit to Lead Optimising Drug Development (2002)

	Pharmacogenomics (2002)

	Signal Transduction Therapeutics (2002)

	Clinical Trials and Data Management (2002)

	Commercial Issues in Drug Delivery 2002 (2002)

	Neurodegenerative Disorders (2002)

	Therapeutic Antibodies (2002)

	Pain Therapeutics (2002)

	Advances in Hypertension and Cardiovascular Therapeutics (2002)

	Contracting and Negotiating Clinical Trials (2002)

	Advances In Target Validation (2002)

	Advances in Anti-Arthritic Agents (2002)

	Supergenerics and Patent Busting (2002)

	Asthma Therapeutics (2002)

	Cosmeceuticals (2002)

	Immune Disorders (2002)

	Superbugs and Superdrugs (2002)

	Gene Therapy (2002)

	Drug Design (2002)

	Angiogenesis and Anti-angiogenesis Therapeutics (2002)

	Controlled Release (2002)

	Speeding up the Drug Manufacturing Process (2002)

	Proteomics (2002)

	Phage Display Technologies (2002)

	Nutraceuticals and Functional Foods (2002)

	Bio-informatics in the 21st Century (2002)

	Laboratory Equipment Validation (2002)

	Anti Inflammatory Therapeutics (2002)

	Combat Engineering (2001)

	Paediatric Medicine (2001)

	Gastrointestinal Drug Development: New and Existing Therapies (2001)

	New Developments in Oligonucleotide Therapeutics (2001)

	Drug Discovery (2001)

	Ostesoporosis Therapies: Strong Bones for Life (2001)

	Phase IV Clinical Trials (2001)

	Chronic Obstructive Pulmonary Disorders (COPD) (2001)

	Tissue Engineering (2001)

	Commercial Issues in CV Drug Development (2001)

	Diabetes 2001 (2001)

	Pharmacotoxicology (2001)

	Research Based Oncology (2001)

	Emerging Pharmaceutical Markets (2001)

	Drug Delivery 2001 - Next Generation Technology (2001)

	Clinical Trials and Data Management (2001)

	Pharmacogenomics and Personalised Medicine (2001)

	From Hit-To-Lead: Optimising Drug Development (2001)

	Theranostics (2001)

	Protein Therapeutics (2001)

	Innovations in Transgenic Technologies (2001)

	Commercial Issues in Oncology Drug Development (2001)

	New Directions in Neurodegenerative Drug Discovery and Development (2001)

	Optimising Drug Development Through Effective Data Management in Clinical Trials (2001)

	Therapeutic Antibodies (2001)

	Shared Services (2001)

	Streamlining Drug Discovery with High throughput Screening (2001)

	Medical Imaging: Benchmarking for Clinical Trial Efficiency (2001)

	Drug Delivery Systems: Exploiting Commercial Opportunities (2001)

	Pain Therapeutics for the New Millennium (2001)

	Technology Commercialisation: (2001)

	Advances in Anti-Arthritic Agents (2001)

	21st Century Clinical Drug Development: Going Global (2001)

	Drug Delivery Systems (2001)

	Super generics and patent busting (2001)

	Regulation, Marketing and Technical Innovation in Cosmetics and Pharmaceuticals (2001)

	Wholesale and Distribution for the Drug Industry (2001)

	Asthma: New Drug Targets and Innovative Therapeutics (2001)

	Superbugs and Superdrugs: Innovations in Anti-infectives (2001)

	HIV Therapeutics: Searching for the Next Generation (2001)

	Pharmacovigiliance: Perspectives & Future Directions (2001)

	Innovations in Drug Target Validation (2001)

	Strategies for Success: Nutraceuticals and Functional Foods (2001)

	Ischaemic Injury: Novel Targets and Therapeutics (2001)

	Cytokines as Drug Targets (2001)

	E-business in the Pharmaceutical and Healthcare Industry (2001)

	Intellectual Property Rights: a Global Perspective for the Drug Industry (2000)

	Successful Outsourcing Strategies in the Drug Industry (2000)

	Diabetes 2000 (2000)

	Win � Win Agreements in the Drug Industry:Strategic Symbiosis (2000)

	Commercial Issues in Oncology Drug Development (2000)

	Cardiovascular Summit 2000: Heart Failure Drugs (2000)

	Strategies in Pharmaceutical Marketing (2000)

	Integration of Electronic Media in Clinical Trials and Data Management (2000)

	Validation of Corporate IT Systems in the Pharmaceutical Industry (2000)

	Osteoporosis Therapies: Strong Bones for Life (2000)

	Drug Delivery Systems: Exploiting Commercial Opportunities (2000)

	Superbugs and Superdrugs : Innovations in Anti Infectives (2000)

	From Genes to Drugs : Integrating Genomics, Proteomics and Bioinformatics (2000)

	3rd European Pharmaceutical Wholesale and Distribution Summit (2000)

	Advances in Anti Arthritic Agents (2000)

	Strategies in the Non/Minimally Invasive Diagnostic Market (1999)

	Impact of New Technologies on Pharmacoeconomics (1999)

	Emerging and Existing Gastrointestinal Drugs (1999)

	Asthma Drug Therapy and Healthcare (1999)

	Diabetes: Novel Therapeutic Developments (1999)

	Advances in Anti Viral Drugs and Anti Viral Vaccine Technologies (1999)

	Osteoporosis Therapies: Strong Bones for Life (1999)

	Therapeutic Cancer Drugs II (1999)

	Drug Delivery Industry: Exploiting Commercial Opportunities (1999)

	Developments in CNS Drugs II: Drugs of Tomorrow (1999)